You must log in to view this page.

Tenax Therapeutics Inc. – Filings and Transcripts

NASDAQ: TENX
Share price (10/6/26): $1.93
Market cap (10/6/26): $72.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Prospectus supplement

Shelf registration

Registration of securities for employees

Ownership Filter

Giordano Christopher Thomas

Staab Thomas R II

Schneeberger Daniel, ADAR1 Capital Management, LLC

News Filter

Investor Presentation

Announces Topline Results From Phase 3 LEVEL Clinical Trial of TNX-103 in Patients With PH-HFpEF

Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission